loadpatents
name:-0.0098288059234619
name:-0.005342960357666
name:-0.0022621154785156
Ries; Uwe Joerg Patent Filings

Ries; Uwe Joerg

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ries; Uwe Joerg.The latest application filed is for "stereoselective process".

Company Profile
1.10.10
  • Ries; Uwe Joerg - Birerach an der Riss DE
  • Ries; Uwe Joerg - Biberach an der Riss DE
  • Ries; Uwe Joerg - Biberach N/A DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Stereoselective process
Grant 10,189,776 - Ries , et al. Ja
2019-01-29
Stereoselective Process
App 20180258031 - Ries; Uwe Joerg ;   et al.
2018-09-13
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Grant 9,670,166 - Gnamm , et al. June 6, 2
2017-06-06
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Grant 9,657,015 - Gnamm , et al. May 23, 2
2017-05-23
Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
App 20160340319 - GNAMM; Christian ;   et al.
2016-11-24
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Grant 9,475,779 - Oost , et al. October 25, 2
2016-10-25
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Grant 9,458,113 - Peters , et al. October 4, 2
2016-10-04
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Grant 9,440,930 - Oost , et al. September 13, 2
2016-09-13
Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity
Grant 9,290,459 - Gnamm , et al. March 22, 2
2016-03-22
Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
App 20160039812 - GNAMM; Christian ;   et al.
2016-02-11
Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
App 20160031829 - OOST; Thorsten ;   et al.
2016-02-04
Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
App 20160031830 - PETERS; Stefan ;   et al.
2016-02-04
Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity
App 20160031831 - OOST; Thorsten ;   et al.
2016-02-04
Crystalline ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1- ,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]- oxy]propyl]-1-piperazinyl]-piperidine-1-acetate difumarate
Grant 8,551,987 - Pachur , et al. October 8, 2
2013-10-08
Preparation process
Grant 8,222,402 - Pachur , et al. July 17, 2
2012-07-17
Novel Compounds
App 20120058994 - Pachur; Kathrin ;   et al.
2012-03-08
Novel Preparation Process
App 20110071286 - Pachur; Kathrin ;   et al.
2011-03-24
Carboxylic acid amides having antithrombotic activity
App 20020151595 - Ries, Uwe Joerg ;   et al.
2002-10-17
Antithrombotic compounds
App 20020151534 - Ries, Uwe Joerg ;   et al.
2002-10-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed